Should You Buy CVS Stock After 12% Drop? Breakup Plan And Q3 Results

Published by

Anjali Belgaumkar

November 5, 2026

Hand holding torn financial chart split between green growth and red crash

CVS Health will break itself into two separate publicly traded companies by the first half of 2028, unwinding the $78 billion Aetna takeover that created the healthcare giant in 2018. One company, keeping the CVS Health name and led by CEO David Joyner, will hold the Aetna insurance arm, the Caremark pharmacy benefit manager, Oak Street Health, Signify Health and the specialty drug unit. The other, called CVS Pharmacy, will run about 9,000 retail stores under group president Prem Shah. Current shareholders will receive stock in both. Investors reacted badly, sending shares down more than 12% on Wednesday, though Joyner said the split comes from a position of strength. Third-quarter sales rose to $108.40 billion, beating forecasts. Leerink Partners’ Michael Cherny said the plan reflects how much the pharmacy business has stabilised.

Trust with CoinPedia:

CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:

All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.